Heather E Allen
Overview
Explore the profile of Heather E Allen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saunders J, Estes K, Kosloski L, Allen H, Dempsey K, Torres-Russotto D, et al.
J Neuroimmune Pharmacol
. 2012 Oct;
7(4):927-38.
PMID: 23054369
Animal models and clinical studies have linked the innate and adaptive immune system to the pathology of Parkinson's disease (PD). Despite such progress, the specific immune responses that influence disease...
2.
Lauer P, Hanson B, Lemmens E, Liu W, Luckett W, Leong M, et al.
Infect Immun
. 2008 Jun;
76(8):3742-53.
PMID: 18541651
Recombinant vaccines derived from the facultative intracellular bacterium Listeria monocytogenes are presently undergoing early-stage clinical evaluation in oncology treatment settings. This effort has been stimulated in part due to preclinical...
3.
Bahjat K, Prell R, Allen H, Liu W, Lemmens E, Leong M, et al.
J Immunol
. 2007 Nov;
179(11):7376-84.
PMID: 18025181
NK cells can identify and eliminate emerging tumors due to altered expression of activating and inhibitory ligands on aberrant cells, a process that is greatly enhanced following NK cell activation....
4.
Yoshimura K, Jain A, Allen H, Laird L, Chia C, Ravi S, et al.
Cancer Res
. 2006 Jan;
66(2):1096-104.
PMID: 16424046
Improved immunization and ex vivo T-cell culture strategies can generate larger numbers and more potent tumor-specific effector cells than previously possible. Nonetheless, the capacity of these cells to eliminate established...
5.
Jain A, Slansky J, Matey L, Allen H, Pardoll D, Schulick R
Ann Surg Oncol
. 2003 Aug;
10(7):810-20.
PMID: 12900373
Background: Granulocyte-macrophage colony-stimulating factor-transduced tumor cell vaccines are less effective against cancer as the interval between metastasis and the initial vaccination increases. Methods: Hepatic metastases were generated in BALB/c mice...